Solventum aims to accelerate innovation in acute wound care, expand its market reach, and deliver enhanced solutions for patients, clinicians, and shareholders
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
Paxton alleges the companies marketed Plavix as a reliable defense against heart attacks, strokes, and blood clots while failing to disclose evidence that the drug could be ineffective or virtually useless for many people
AVT03 is a biosimilar of Amgen's Prolia (denosumab 60 mg/mL) and Xgeva (denosumab 70 mg/mL), which are used to treat various bone conditions
The partnership will enable rapid and reliable product delivery
Winlevi is authorized in EU for the treatment of acne vulgaris
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
The full approval is based on the results from the pivotal Phase 3 EPCORE FL-1 study
Subscribe To Our Newsletter & Stay Updated
